Diadenosinc pentaphosphate vasodilates the forearm vascular bed: Inhibition by theophylline and augmentation by dipyridamole

Clinical Pharmacology and Therapeutics

Volumn 71, Issue 6, 2002, Pages 448-456

  Van Ginneken, Egidia E M ^a   Rongen, Gerard A ^a   Russel, Frans G M ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; DIADENOSINE PENTAPHOSPHATE; DIPYRIDAMOLE; EDETIC ACID; THEOPHYLLINE; DIDANOSINE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION; VASOMOTOR REFLEX; DRUG ANTAGONISM; DRUG POTENTIATION; FOREARM; METABOLISM; REFERENCE VALUE; VASCULARIZATION;

ADULT; DIDANOSINE; DIPYRIDAMOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EDETIC ACID; FEMALE; FOREARM; HUMANS; MALE; REFERENCE VALUES; THEOPHYLLINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0035983919     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.124469     Document Type: Article

References (40)

1. The effects of diadenosine polyphosphates on the cardiovascular system
2. Identification and characterization of P(1), P(7)-Di(adenosine-5′)-heptaphosphate from human platelets
3. Diadenosine phosphates and the physiological control of blood pressure
4. Diadenosine tetraphosphate is co-released with ATP and catecholamines from bovine adrenal medulla
5. Diadenosine 5′,5″-P1,P4-tetraphosphate (Ap4A), ATP and catecholamine content in bovine adrenal medulla, chromaffin granules and chromaffin cells
6. Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates
7. Transmission of hypertension in rats by cross circulation
8. Effect of plasma from essential hypertensives on tension of aortic strips
9. A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives
10. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system
11. Characterization of ATP-induced vasodilation in the human forearm vascular bed
12. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney
13. Pre- and postjunctional effects of diadenosine polyphosphates in the guinea-pig vas deferens
14. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries
15. Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries
16. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection
17. Flow ratios to express results obtained with the human in vivo "perfused forearm technique"
18. Theophylline is an antagonist of adenosine in human forearm arterioles
19. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans
20. Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade
21. Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries
22. Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes
23. Identification and partial characterization of an adenosine(5′)tetraphospho(5′)adenosine hydrolase on intact bovine aortic endothelial cells
24. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs
25. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine
26. Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5′-nucleotide phosphodiesterase activity
27. Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells
28. Calf and forearm blood flow in patients with primary hyperparathyroidism and in control subjects
29. Correlation of increased serum calcium with elevated blood pressure and vascular resistance during calcium infusion in normotensive man
30. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans
31. Effect of diadenosine phosphates on human umbilical vessels: Novel platelet-derived vasoconstrictors
32. Diadenosine polyphosphates' action on calcium and vessel contraction
33. Heterogenous vascular effects of AP5A in different rat resistance arteries are due to heterogenous distribution of P2X and P2Y(1) purinoceptors
34. Ecto-enzymatic hydrolysis of diadenosine polyphosphates by cultured adrenomedullary vascular endothelial cells
35. Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig
36. Renal hemodynamic effects of exogenously administered adenosine and polyadenylic acid
37. Analysis of the cardiovascular response to diadenosine pentaphosphate in the anaesthetised rat
38. Influence of purinoceptor antagonism on diadenosine pentaphosphate-induced hypotension in anesthetized rats
39. A vascular abnormality in hypertension. A study of blood flow in the forearm